Van Eck Associates Corp Bio Rad Laboratories, Inc. Transaction History
Van Eck Associates Corp
- $80.1 Billion
- Q3 2024
A detailed history of Van Eck Associates Corp transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Van Eck Associates Corp holds 1,303,752 shares of BIO stock, worth $431 Million. This represents 0.55% of its overall portfolio holdings.
Number of Shares
1,303,752
Previous 659,222
97.77%
Holding current value
$431 Million
Previous $180 Million
142.65%
% of portfolio
0.55%
Previous 0.26%
Shares
10 transactions
Others Institutions Holding BIO
# of Institutions
456Shares Held
18.2MCall Options Held
19.5KPut Options Held
13.9K-
Vanguard Group Inc Valley Forge, PA1.91MShares$631 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$513 Million0.01% of portfolio
-
Veritas Asset Management LLP1.09MShares$359 Million3.03% of portfolio
-
First Eagle Investment Management, LLC713KShares$236 Million0.5% of portfolio
-
Select Equity Group, L.P. New York, NY708KShares$234 Million0.95% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.15B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...